Avoid injecting it into patients who have a hypersensitivity to hyaluronic acid, Lidocaine, or a similar local anesthetic, or patients who have a bleeding disorder or are taking anticoagulants or thrombolytics. Be cautious when treating patients who have had rhinoplasty since it could affect the vascular supply; when treating areas with limited collateral circulation since it could increase the risk of ischemia; when treating areas close to a permanent implant or a non-RESTYLANE® filler; and when treating the periorbital eye area or other areas with limited soft tissue support because lumps could form. You should not use this product to treat patients who have thin skin, the tendency to form edemas, or pre-existing dark eye circles. Avoid injecting the skin booster into areas with inflammation, infection, or tumors, and be aware that the injections can reactivate herpes infections. If your patients are taking aspirin, non-steroidal anti-inflammatory drugs, or similar drugs affecting platelet function, they may be at an increased risk of bruising or bleeding at the injection site. The manufacturers have not tested this skin booster in pregnant or breastfeeding women or in children.
Since this product contains Lidocaine, be aware of your patient’s total dose of anesthetic. After their treatment, your patients should avoid extreme cold or excessive sun until their redness and swelling have subsided.
These may not be all the precautions related to using this product. Refer to your product leaflet for more information.